X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15550) 15550
Publication (1709) 1709
Newspaper Article (391) 391
Book Review (284) 284
Newsletter (129) 129
Book Chapter (126) 126
Magazine Article (63) 63
Government Document (54) 54
Trade Publication Article (47) 47
Conference Proceeding (29) 29
Book / eBook (24) 24
Dissertation (24) 24
Web Resource (4) 4
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10059) 10059
male (9223) 9223
index medicus (7454) 7454
prostate cancer (6049) 6049
androgens (5173) 5173
animals (4356) 4356
oncology (3673) 3673
female (3377) 3377
testosterone (2886) 2886
androgen receptor (2814) 2814
cancer (2683) 2683
endocrinology & metabolism (2557) 2557
prostatic neoplasms - drug therapy (2438) 2438
prostatic neoplasms - pathology (2335) 2335
aged (2291) 2291
middle aged (2276) 2276
urology & nephrology (2250) 2250
care and treatment (2119) 2119
research (1884) 1884
androgen antagonists - therapeutic use (1815) 1815
adult (1695) 1695
mice (1643) 1643
prostate (1602) 1602
expression (1566) 1566
cell line, tumor (1540) 1540
health aspects (1476) 1476
receptors, androgen - metabolism (1449) 1449
prostatic neoplasms - metabolism (1432) 1432
analysis (1391) 1391
men (1329) 1329
testosterone - blood (1232) 1232
apoptosis (1230) 1230
radiotherapy (1224) 1224
metastasis (1210) 1210
gene expression (1191) 1191
article (1178) 1178
biochemistry & molecular biology (1141) 1141
rats (1126) 1126
cell biology (1122) 1122
treatment outcome (1104) 1104
androgen (1075) 1075
radical prostatectomy (1036) 1036
risk factors (1030) 1030
carcinoma (1029) 1029
hormones (1024) 1024
proteins (1000) 1000
aged, 80 and over (989) 989
physiological aspects (979) 979
prostatic neoplasms - genetics (957) 957
suppression (942) 942
receptors, androgen - genetics (917) 917
therapy (916) 916
prostatic neoplasms - radiotherapy (906) 906
prostatic neoplasms - therapy (905) 905
tumors (893) 893
androgen deprivation therapy (885) 885
androgens - metabolism (880) 880
development and progression (874) 874
estrogen (855) 855
castration (842) 842
growth (820) 820
cancer therapies (818) 818
prostate-specific antigen - blood (817) 817
signal transduction (801) 801
medicine (800) 800
antineoplastic agents, hormonal - therapeutic use (756) 756
genetic aspects (727) 727
medicine & public health (720) 720
urology (720) 720
orchiectomy (711) 711
radiation-therapy (699) 699
gene-expression (695) 695
survival (692) 692
time factors (690) 690
research article (688) 688
chemotherapy (686) 686
progression (680) 680
cells (675) 675
androgen suppression (654) 654
disease progression (642) 642
cell proliferation (639) 639
androgen-deprivation therapy (637) 637
androgens - pharmacology (637) 637
prostatic neoplasms - blood (633) 633
pharmacology & pharmacy (627) 627
prognosis (621) 621
patients (620) 620
multidisciplinary sciences (613) 613
studies (613) 613
prostatic neoplasms - mortality (612) 612
women (595) 595
activation (579) 579
prostate-cancer (579) 579
adolescent (571) 571
androgens - blood (571) 571
testosterone - pharmacology (571) 571
risk (566) 566
gene expression regulation, neoplastic (558) 558
androgen antagonists - adverse effects (545) 545
quality of life (545) 545
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (16) 16
Online Resources - Online (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Searching (1) 1
St. Michael's Hospital - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (16003) 16003
French (156) 156
German (101) 101
Spanish (33) 33
Japanese (24) 24
Russian (10) 10
Chinese (4) 4
Portuguese (4) 4
Dutch (3) 3
Turkish (3) 3
Italian (2) 2
Polish (2) 2
Arabic (1) 1
Hungarian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 10, pp. 1076 - 1089
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 98, Issue 2, pp. 275 - 285
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2009, Volume 360, Issue 24, pp. 2516 - 2527
A current standard treatment for locally advanced prostate cancer is external-beam radiotherapy combined with 3 years of androgen suppression. Adverse events,... 
PHASE-III TRIAL | DEPRIVATION THERAPY | IRRADIATION | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | EORTC | RANDOMIZED-TRIAL | QUALITY-OF-LIFE | RADIOTHERAPY | RADIATION-THERAPY | ADJUVANT | Anilides - therapeutic use | Prostatic Neoplasms - radiotherapy | Follow-Up Studies | Anilides - adverse effects | Humans | Middle Aged | Male | Gonadotropin-Releasing Hormone - analogs & derivatives | Flutamide - adverse effects | Treatment Failure | Aged, 80 and over | Adult | Flutamide - therapeutic use | Prostatic Neoplasms - drug therapy | Drug Administration Schedule | Proportional Hazards Models | Combined Modality Therapy | Prostatic Neoplasms - mortality | Disease-Free Survival | Tosyl Compounds - adverse effects | Heart Diseases - mortality | Tosyl Compounds - therapeutic use | Quality of Life | Radiotherapy, Conformal - adverse effects | Aged | Androgen Antagonists - administration & dosage | Androgen Antagonists - adverse effects | Nitriles - adverse effects | Nitriles - therapeutic use | Heart attacks | Medical treatment | Mortality | Radiation therapy | Prostate cancer | Cancer therapies | Quality of life | Index Medicus | Abridged Index Medicus | Androgen Antagonists | Anilides | Life Sciences | Prostatic Neoplasms | Flutamide | Heart Diseases | Radiotherapy, Conformal | Gonadotropin-Releasing Hormone | Nitriles | Tosyl Compounds | Cancer
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2012, Volume 367, Issue 10, pp. 895 - 903
Journal Article
Veterinary Clinics of North America - Small Animal Practice, ISSN 0195-5616, 07/2018, Volume 48, Issue 4, pp. 595 - 603
Since 1952, scientists have studied estrus suppression in dogs. Estrus suppression in dogs must be safe and reliable. Medications used for estrus suppression... 
Agonist | Hormonal downregulation | Antagonist | Androgen | GnRH | Progestogen | MEDROXYPROGESTERONE ACETATE | CONTRACEPTIVE STEROIDS | CHLORMADINONE ACETATE | LUTEINIZING-HORMONE | ANESTROUS BITCHES | MAMMARY-TUMORS | GROWTH-HORMONE | POPULATION-CONTROL | VETERINARY SCIENCES | GNRH-AGONIST | DESLORELIN IMPLANT
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 07/2013, Volume 288, Issue 27, pp. 19359 - 19369
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2016, Volume 34, Issue 15, pp. 1748 - 1756
PURPOSE: Up to 30% of patients who undergo radiation for intermediate- or high-risk localized prostate cancer relapse biochemically within 5 years. We assessed... 
PHASE-III TRIAL | THERAPY | ONCOLOGY | DEPRIVATION | QUALITY-OF-LIFE | RANDOMIZED CONTROLLED-TRIAL | RADIOTHERAPY | RTOG | DURATION | Radiotherapy Dosage | Humans | Middle Aged | Aged, 80 and over | Androgen Antagonists - therapeutic use | Adult | Male | Aged | Combined Modality Therapy | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Prostatic Neoplasms - therapy
Journal Article
Journal Article